Trademark Overview
On Thursday, August 24, 2023, a trademark application was filed for BIO79 VENTURE PARTNERS with the United States Patent and Trademark Office. The USPTO has given the BIO79 VENTURE PARTNERS trademark a serial number of 98149128. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, August 8, 2024. This trademark is owned by Bio79 Venture Partners, LLC. The BIO79 VENTURE PARTNERS trademark is filed in the Advertising, Business and Retail Services and Insurance & Financial Services categories with the following description:
venture capital services, namely, providing financing to startup and emerging companies that are believed to have long-term growth potential in the field of innovative pharmaceutical and biotechnology products; providing venture capital, development capital, private equity and investment funding to startup companies and small businesses in the field of innovative pharmaceutical and biotechnology products; venture capital financing in the field of innovative pharmaceutical and biotechnology products; financial services, namely, investment management of strategic venture funds focused on innovative pharmaceutical and biotechnology products; strategic financial investments in startup and emerging companies that are believed to have long-term growth potential in the field of innovative pharmaceutical and biotechnology products
new business venture development and formation consulting services in the field of innovative pharmaceutical and biotechnology products; business support services, namely, business consulting, business development, business venture and formation consulting, business growth consulting, and business management to startup and emerging companies in the in the field of innovative pharmaceutical and biotechnology products; strategic management and business advisory services in the fields of management, business development, licensing, merger and acquisition, venture capital and financing services in the field of innovative pharmaceutical and biotechnology products